Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
N van Es, M Coppens, S Schulman… - Blood, The Journal …, 2014 - ashpublications.org
In the last 4 years, 6 phase 3 trials including a total of 27 023 patients with venous
thromboembolism (VTE) compared a direct oral anticoagulant (DOAC) with vitamin K …
thromboembolism (VTE) compared a direct oral anticoagulant (DOAC) with vitamin K …
Pulmonary embolism: update on management and controversies
L Duffett, LA Castellucci, MA Forgie - Bmj, 2020 - bmj.com
Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis
S Schulman, AK Kakkar, SZ Goldhaber, S Schellong… - Circulation, 2014 - Am Heart Assoc
Background—Dabigatran and warfarin have been compared for the treatment of acute
venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those …
venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those …
Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis
S Chatterjee, A Chakraborty, I Weinberg, M Kadakia… - Jama, 2014 - jamanetwork.com
Importance Thrombolytic therapy may be beneficial in the treatment of some patients with
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …
Update on guidelines for the management of cancer‐associated thrombosis
MB Streiff, SA Abutalib, D Farge, M Murphy… - The …, 2021 - academic.oup.com
Cancer‐associated thrombosis (CAT) is a major cause of morbidity and mortality in patients
with cancer. Over the past 2 decades, enormous advances have been made in the …
with cancer. Over the past 2 decades, enormous advances have been made in the …
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with …
D Farge, H Bounameaux, B Brenner… - The Lancet …, 2016 - thelancet.com
Venous thromboembolism (VTE) is the second leading cause of death in patients with
cancer. These patients are at an increased risk of developing VTE and are more likely to …
cancer. These patients are at an increased risk of developing VTE and are more likely to …
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic …
Despite the discovery and application of many parenteral (unfractionated and low-molecular-
weight heparins) and oral anticoagulant vitamin K antagonist (VKA) drugs, the prevention …
weight heparins) and oral anticoagulant vitamin K antagonist (VKA) drugs, the prevention …
[HTML][HTML] Guidance for the treatment of deep vein thrombosis and pulmonary embolism
This guidance document focuses on the diagnosis and treatment of venous
thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by combining …
thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by combining …
NCCN guidelines insights: cancer-associated venous thromboembolic disease, version 2.2018
MB Streiff, B Holmstrom, D Angelini, A Ashrani… - Journal of the National …, 2018 - jnccn.org
Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity
and mortality. VTE prevention and treatment are more complex in patients with cancer. The …
and mortality. VTE prevention and treatment are more complex in patients with cancer. The …
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial
P Mismetti, S Laporte, O Pellerin, PV Ennezat… - Jama, 2015 - jamanetwork.com
Importance Although retrievable inferior vena cava filters are frequently used in addition to
anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is …
anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is …